Copyright Reports & Markets. All rights reserved.

Global Solid Tumor Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Solid Tumor Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Solid Tumor Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Chemotherapy
    • 1.4.3 Hormone Therapy
    • 1.4.4 Immunotherapy
    • 1.4.5 Targeted Therapy
  • 1.5 Market by Application
    • 1.5.1 Global Solid Tumor Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Breast Cancer
    • 1.5.3 Lung Cancer
    • 1.5.4 Colorectal Cancer
    • 1.5.5 Prostate Cancer
    • 1.5.6 Cervical Cancer
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Solid Tumor Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Solid Tumor Therapeutics Growth Trends by Regions
    • 2.2.1 Solid Tumor Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Solid Tumor Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Solid Tumor Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Solid Tumor Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Solid Tumor Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Solid Tumor Therapeutics Players by Market Size
    • 3.1.1 Global Top Solid Tumor Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Solid Tumor Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Solid Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Solid Tumor Therapeutics Market Concentration Ratio
    • 3.2.1 Global Solid Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Solid Tumor Therapeutics Revenue in 2019
  • 3.3 Solid Tumor Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Solid Tumor Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Solid Tumor Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Solid Tumor Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Solid Tumor Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Solid Tumor Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Solid Tumor Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Solid Tumor Therapeutics Market Size (2015-2020)
  • 6.2 Solid Tumor Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Solid Tumor Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Solid Tumor Therapeutics Market Size (2015-2020)
  • 7.2 Solid Tumor Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Solid Tumor Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Solid Tumor Therapeutics Market Size (2015-2020)
  • 8.2 Solid Tumor Therapeutics Key Players in China (2019-2020)
  • 8.3 China Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Solid Tumor Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Solid Tumor Therapeutics Market Size (2015-2020)
  • 9.2 Solid Tumor Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Solid Tumor Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Solid Tumor Therapeutics Market Size (2015-2020)
  • 10.2 Solid Tumor Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Solid Tumor Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Solid Tumor Therapeutics Market Size (2015-2020)
  • 11.2 Solid Tumor Therapeutics Key Players in India (2019-2020)
  • 11.3 India Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Solid Tumor Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Solid Tumor Therapeutics Market Size (2015-2020)
  • 12.2 Solid Tumor Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Solid Tumor Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Solid Tumor Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Hoffmann-La Roche
    • 13.1.1 Hoffmann-La Roche Company Details
    • 13.1.2 Hoffmann-La Roche Business Overview
    • 13.1.3 Hoffmann-La Roche Solid Tumor Therapeutics Introduction
    • 13.1.4 Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2015-2020))
    • 13.1.5 Hoffmann-La Roche Recent Development
  • 13.2 Johnson & Johnson
    • 13.2.1 Johnson & Johnson Company Details
    • 13.2.2 Johnson & Johnson Business Overview
    • 13.2.3 Johnson & Johnson Solid Tumor Therapeutics Introduction
    • 13.2.4 Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.2.5 Johnson & Johnson Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis Solid Tumor Therapeutics Introduction
    • 13.3.4 Novartis Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 AstraZeneca
    • 13.4.1 AstraZeneca Company Details
    • 13.4.2 AstraZeneca Business Overview
    • 13.4.3 AstraZeneca Solid Tumor Therapeutics Introduction
    • 13.4.4 AstraZeneca Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.4.5 AstraZeneca Recent Development
  • 13.5 Biogen Idec
    • 13.5.1 Biogen Idec Company Details
    • 13.5.2 Biogen Idec Business Overview
    • 13.5.3 Biogen Idec Solid Tumor Therapeutics Introduction
    • 13.5.4 Biogen Idec Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.5.5 Biogen Idec Recent Development
  • 13.6 Boehringer Ingelheim
    • 13.6.1 Boehringer Ingelheim Company Details
    • 13.6.2 Boehringer Ingelheim Business Overview
    • 13.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Introduction
    • 13.6.4 Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.6.5 Boehringer Ingelheim Recent Development
  • 13.7 GlaxoSmithKline
    • 13.7.1 GlaxoSmithKline Company Details
    • 13.7.2 GlaxoSmithKline Business Overview
    • 13.7.3 GlaxoSmithKline Solid Tumor Therapeutics Introduction
    • 13.7.4 GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.7.5 GlaxoSmithKline Recent Development
  • 13.8 Eli Lilly
    • 13.8.1 Eli Lilly Company Details
    • 13.8.2 Eli Lilly Business Overview
    • 13.8.3 Eli Lilly Solid Tumor Therapeutics Introduction
    • 13.8.4 Eli Lilly Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.8.5 Eli Lilly Recent Development
  • 13.9 Kyowa Hakko Kirin
    • 13.9.1 Kyowa Hakko Kirin Company Details
    • 13.9.2 Kyowa Hakko Kirin Business Overview
    • 13.9.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Introduction
    • 13.9.4 Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.9.5 Kyowa Hakko Kirin Recent Development
  • 13.10 Abbott Laboratories
    • 13.10.1 Abbott Laboratories Company Details
    • 13.10.2 Abbott Laboratories Business Overview
    • 13.10.3 Abbott Laboratories Solid Tumor Therapeutics Introduction
    • 13.10.4 Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 13.10.5 Abbott Laboratories Recent Development
  • 13.11 Baxter International
    • 10.11.1 Baxter International Company Details
    • 10.11.2 Baxter International Business Overview
    • 10.11.3 Baxter International Solid Tumor Therapeutics Introduction
    • 10.11.4 Baxter International Revenue in Solid Tumor Therapeutics Business (2015-2020)
    • 10.11.5 Baxter International Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Solid Tumor Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Solid Tumor Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Hoffmann-La Roche
    Johnson & Johnson
    Novartis
    AstraZeneca
    Biogen Idec
    Boehringer Ingelheim
    GlaxoSmithKline
    Eli Lilly
    Kyowa Hakko Kirin
    Abbott Laboratories
    Baxter International

    Market segment by Type, the product can be split into
    Chemotherapy
    Hormone Therapy
    Immunotherapy
    Targeted Therapy
    Market segment by Application, split into
    Breast Cancer
    Lung Cancer
    Colorectal Cancer
    Prostate Cancer
    Cervical Cancer
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now